Literature DB >> 20402747

Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life.

A Chiò1, A Vignola, E Mastro, A Dei Giudici, B Iazzolino, A Calvo, C Moglia, A Montuschi.   

Abstract

OBJECTIVE: To evaluate the frequency of neurobehavioral symptoms related to FTLD in a consecutive series of amyotrophic lateral sclerosis (ALS) patients and to assess their influence on patients' and caregivers' mood, burden, and quality of life.
METHODS: A total of 70 couples of ALS patients and their caregivers consecutively seen in our ALS clinic were separately interviewed using a battery of tests assessing frontotemporal-related neurobehavioral symptoms, emotional status, and quality of life. Patients' behavioral abnormalities were assessed with the Frontal Systems Behavior Scale (FrSBe). Caregiver burden was assessed with the Caregiver Burden Inventory (CBI).
RESULTS: According to caregivers' evaluations, 34 (48.6%) patients had FrSBe pathological scores at the time of the interview. According to patients' evaluation, 9 (12.9%) patients had pathological scores at the time of the interview. In caregivers' assessment, at the time of the interview the most commonly impaired neurobehavioral domain was apathy (39 patients, 55.7%), followed by executive dysfunction (32, 45.7%) and disinhibition (18, 25.7%). Neurobehavioral symptoms were related to the presence of bulbar symptoms at the time of the interview, but not to patients' age, gender, or physical status (ALS-FRS score). Patients' neurobehavioral symptoms were significantly related to lower caregivers' quality of life, highest depression, and highest burden, both in univariate and in multivariable analyses.
CONCLUSIONS: Neurobehavioral symptoms were present in 50% of our ALS patients and were related to bulbar symptoms. They have a profound negative impact on caregivers' psychological status and were highly related with caregivers' burden.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.

Entities:  

Mesh:

Year:  2010        PMID: 20402747     DOI: 10.1111/j.1468-1331.2010.03016.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  36 in total

1.  Frontal systems deficits in stimulant-dependent patients: evidence of pre-illness dysfunction and relationship to treatment response.

Authors:  Theresa M Winhusen; Eugene C Somoza; Daniel F Lewis; Frankie B Kropp; Viviana Elizabeth Horigian; Bryon Adinoff
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

2.  Caregiver burden in frontotemporal degeneration and corticobasal syndrome.

Authors:  Nicole Armstrong; Nicole Schupf; Jordan Grafman; Edward D Huey
Journal:  Dement Geriatr Cogn Disord       Date:  2013-09-10       Impact factor: 2.959

3.  Apathy and its impact on patient outcome in amyotrophic lateral sclerosis.

Authors:  J Caga; S Hsieh; E Highton-Williamson; M C Zoing; E Ramsey; E Devenney; R M Ahmed; M C Kiernan
Journal:  J Neurol       Date:  2017-11-30       Impact factor: 4.849

4.  Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.

Authors:  Jürgen Keller; Martin Gorges; Hannah T Horn; Helena E A Aho-Özhan; Elmar H Pinkhardt; Ingo Uttner; Jan Kassubek; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

5.  Alexithymia in Amyotrophic Lateral Sclerosis and Its Neural Correlates.

Authors:  Soumia Benbrika; Franck Doidy; Laurence Carluer; Audrey Mondou; Marie-Sonia Buhour; Francis Eustache; Fausto Viader; Béatrice Desgranges
Journal:  Front Neurol       Date:  2018-07-24       Impact factor: 4.003

6.  Cognitive impairment across ALS clinical stages in a population-based cohort.

Authors:  Adriano Chiò; Cristina Moglia; Antonio Canosa; Umberto Manera; Rosario Vasta; Maura Brunetti; Marco Barberis; Lucia Corrado; Sandra D'Alfonso; Enrica Bersano; Maria Francesca Sarnelli; Valentina Solara; Jean Pierre Zucchetti; Laura Peotta; Barbara Iazzolino; Letizia Mazzini; Gabriele Mora; Andrea Calvo
Journal:  Neurology       Date:  2019-08-13       Impact factor: 9.910

7.  ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability.

Authors:  Lucio Tremolizzo; Andrea Lizio; Gabriella Santangelo; Susanna Diamanti; Christian Lunetta; Francesca Gerardi; Sonia Messina; Stefania La Foresta; Nilo Riva; Yuri Falzone; Massimo Filippi; Susan C Woolley; Valeria Ada Sansone; Mattia Siciliano; Carlo Ferrarese; Ildebrando Appollonio
Journal:  Neurol Sci       Date:  2019-12-05       Impact factor: 3.307

8.  Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Jürgen Keller; Martin Gorges; Helena E A Aho-Özhan; Ingo Uttner; Erich Schneider; Jan Kassubek; Elmar H Pinkhardt; Albert C Ludolph; Dorothée Lulé
Journal:  J Vis Exp       Date:  2016-10-13       Impact factor: 1.355

9.  Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).

Authors:  Christopher Crockford; Judith Newton; Katie Lonergan; Caoifa Madden; Iain Mays; Meabhdh O'Sullivan; Emmet Costello; Marta Pinto-Grau; Alice Vajda; Mark Heverin; Niall Pender; Ammar Al-Chalabi; Orla Hardiman; Sharon Abrahams
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-07       Impact factor: 4.092

10.  Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study.

Authors:  Poul Jennum; Rikke Ibsen; Stephen Wørlich Pedersen; Jakob Kjellberg
Journal:  J Neurol       Date:  2012-10-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.